FISPB
GILD icon

Fideuram - Intesa Sanpaolo Private Banking’s Gilead Sciences GILD Stock Holding History

Fideuram - Intesa Sanpaolo Private Banking’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Sell
148,589
-99,130
-40% -$13.1M 0.56% 44
2026
Q1 		$34.5M Sell
247,719
-166,156
-40% -$23.3M 1.21% 15
2025
Q4 		$50.8M Buy
+413,875
New +$50.3M 1.83% 7

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking's GILD Position: Q2 2026 in Review

Fideuram - Intesa Sanpaolo Private Banking reduced its Gilead Sciences (GILD) stake by 40% in Q2 2026, selling an estimated $13.1M and leaving 148,589 shares worth $18.8M. The position accounts for 0.56% of the portfolio, ranked #44.

Fideuram - Intesa Sanpaolo Private Banking first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $50.8M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fideuram - Intesa Sanpaolo Private Banking held 148,589 shares of Gilead Sciences worth $18.8M as of Q2 2026.
  • Fideuram - Intesa Sanpaolo Private Banking sold 99,130 Gilead Sciences shares in Q2 2026, an estimated $13.1M.
  • Gilead Sciences made up 0.56% of Fideuram - Intesa Sanpaolo Private Banking's portfolio in Q2 2026, its #44 holding.
  • Fideuram - Intesa Sanpaolo Private Banking first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Fideuram - Intesa Sanpaolo Private Banking's Gilead Sciences position peaked at $50.8M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fideuram - Intesa Sanpaolo Private Banking's 13F filing for Q2 2026, filed 23 Jul 2026.